Cholesterol News and Research

RSS

Cholesterol is a waxy, fat-like substance made in the liver, and found in the blood and in all cells of the body. Cholesterol is important for good health and is needed for making cell walls, tissues, hormones, vitamin D, and bile acid.

Dietary cholesterol is not a primary factor for coronary heart disease

Contrary to the established view, current data suggest that dietary cholesterol is not a primary factor of or causes heart disease - with the possible exception of the genetic forms of familial hypercholesterolemias. For instance, recent clinical trials evaluating the effect of cholesterol-lowering drugs on the development of chronic heart failure, diabetes and stroke have yielded disappointing results.

2 Nov 2009

Study: Charcoal lessens atherosclerotic lesions in mice with kidney damage

Charcoal may provide a new approach to managing the high rate of heart disease in patients with advanced kidney disease, according to preliminary research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

2 Nov 2009

Conference to address the need for gender specific diagnostic strategies for women

The 'Red Alert for Women's Hearts' conference, taking place on 5 November 2009, at the European Heart House, Sophia Antipolis, France, will address the subject of Women and CVD. The conference is jointly organised by the European Society of Cardiology (ESC) and European Heart Network (EHN), as part of Work Package 6 of the EuroHeart project .

31 Oct 2009

Married men more likely to seek professional healthcare compared to single counterparts

According to a Mintel survey of adult men, those who are married are more likely to have had a physical with a registered physician within the past year compared to their single counterparts (55% versus 35%).

31 Oct 2009

VIA Pharmaceuticals to discuss its cardio-metabolic product portfolio at the Target 2009 conference

VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.

30 Oct 2009

Current measurement of diabetes care quality is complex and cumbersome, says NCDP

The National Changing Diabetes® Program (NCDP) announced today results of a study that found extraordinary variety in the measurement of clinical processes critical to optimal diabetes management such as blood pressure and glucose levels.

30 Oct 2009

Majority of consumers say food scoring system would influence their purchasing decisions

Grocery shoppers in a new study report that a one to 100-point food rating system would help them choose what goes into their carts.

30 Oct 2009

Researchers show Simvastatin prevents Parkinson's disease from progressing further

Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.

30 Oct 2009

VIVUS presents additional data on Qnexa Phase 3 trials

VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.

30 Oct 2009

NIH launches randomized trail to determine whether lower BP goal cuts the risk of heart and kidney diseases

The National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline.

30 Oct 2009

CCS updates the Canadian guidelines for the management and treatment of dyslipidemia

The management of dyslipidemia continues to evolve and despite improvements in recurrent cardiovascular events and a decrease in cardiac mortality, cardiovascular disease (CVD) still represents the major burden of disease in this country.

29 Oct 2009

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today its participation in a $2.4 million research grant awarded to the University of Pennsylvania under the “American Recovery and Reinvestment Act of 2009”. The new grant will fund research over two years in the laboratories of Daniel Rader, M.D. of the University of Pennsylvania School of Medicine, Sekar Kathiresan, M.D. of Massachusetts General Hospital (MGH) and Harvard Medical School, and Alnylam.

29 Oct 2009

Publix Supermarkets to sell HeartSavior and LipidShield Plus

New Health Corp. is proud to announce that HeartSavior(TM) and LipidShield® Plus are now available at Publix Supermarkets.

29 Oct 2009

Long-term effects of statin therapy could lead to transient or permanent cognitive impairment

Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. However, a study in the October Journal of Lipid Research finds that similar statin drugs can have profoundly different effects on brain cells -both beneficial and detrimental.

29 Oct 2009

Study on quality of health care for US-born Latinos and undocumented Latinos

Where Latinos are born and their immigration status affect the quality of health care they receive in the US, according to Professor Michael Rodr-guez and colleagues from the UCLA Department of Family Medicine and the Network for Multicultural Research on Health and Healthcare based in Los Angeles, California.

29 Oct 2009

InfoMedics launches doctor-patient feedback programs

InfoMedics, Inc. has implemented patient feedback programs to improve doctor-patient communication and enhance the impact of marketing programs for biopharmaceutical brands through every phase and challenge of the product life cycle: disease state awareness, early experience, branded launch campaign, growth, mature product and patient compliance.

29 Oct 2009

Cholesterol News and Research

Further Reading

Dietary cholesterol is not a primary factor for coronary heart disease

Study: Charcoal lessens atherosclerotic lesions in mice with kidney damage

Conference to address the need for gender specific diagnostic strategies for women

Married men more likely to seek professional healthcare compared to single counterparts

VIA Pharmaceuticals to discuss its cardio-metabolic product portfolio at the Target 2009 conference

Current measurement of diabetes care quality is complex and cumbersome, says NCDP

Majority of consumers say food scoring system would influence their purchasing decisions

Researchers show Simvastatin prevents Parkinson's disease from progressing further

VIVUS presents additional data on Qnexa Phase 3 trials

NIH launches randomized trail to determine whether lower BP goal cuts the risk of heart and kidney diseases

CCS updates the Canadian guidelines for the management and treatment of dyslipidemia

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Publix Supermarkets to sell HeartSavior and LipidShield Plus

Long-term effects of statin therapy could lead to transient or permanent cognitive impairment

Study on quality of health care for US-born Latinos and undocumented Latinos

InfoMedics launches doctor-patient feedback programs

Impact of wellness programs on pharmaceutical, diagnostic and device markets

Sixth round of recipients of Pfizer Cardiovascular Research Awards Program announced

New CCS guidelines and position papers for physicians and nurse practitioners

Diabetes alerts for seniors from Always Best Care Senior Services

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News